The food supplement glucosamine has been claimed to modify progression of osteoarthritis1 and is being extensively marketed as a treatment for patients with the condition. In fact, the UK annual market for glucosamine is now estimated to be over £10 million.2 Here, we examine whether the supplement has a place in the management of osteoarthritis.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.